title: Beneficial effects of LY203647, a novel leukotriene C4/D4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS.
abstract: The sulfidopeptide leukotrienes (LT) have been implicated as important pathophysiological mediators in septic shock. To further define the role of these compounds, we utilized a porcine endotoxicosis model to study the effects of pre- and concurrent treatment with LY203647, a novel LT receptor antagonist. Pentobarbital-anesthetized pigs (13-20 kg) were mechanically ventilated with 100% O2. Superior mesenteric arterial flow (Qsma) was measured using an ultrasonic flow probe. Ileal intramucosal hydrogen ion concentration, [H+]1, was estimated tonometrically. Pigs in groups I and II were infused with endotoxin (250 micrograms/kg) and resuscitated with saline (1.2 ml/kg min). Group I (n = 8) were controls; Group II (n = 8) were pretreated with LY203647 (30 mg/kg bolus, then 10 mg/kg h). Treatment with LY203647 persistently and significantly (P less than .05) improved post-LPS pO2 and transiently improved Qsma. Treatment with LY203647 did not affect [H+]1. Lung extravascular wet-to-dry weight ratios were 7.13 +/- .33 and 5.43 +/- .09 in groups I and II, respectively (P less than .001). These data suggest that sulfidopeptide LT are important mediators of key pathophysiologic events in this porcine model of endotoxic shock and the adult respiratory distress syndrome (ARDS).
authors.affiliation: Department of Surgery, University of Massachusetts Medical Center, Worcester 01655.
authors.forename: S M
authors.initials: SM
authors.lastname: Cohn
authors.forename: K L
authors.initials: KL
authors.lastname: Kruithoff
authors.forename: H R
authors.initials: HR
authors.lastname: Rothschild
authors.forename: H L
authors.initials: HL
authors.lastname: Wang
authors.forename: J B
authors.initials: JB
authors.lastname: Antonsson
authors.forename: M P
authors.initials: MP
authors.lastname: Fink
mesh_terms: D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D008070:Lipopolysaccharides / Q000633:toxicity; D008168:Lung / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D012128:Respiratory Distress Syndrome / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D013189:SRS-A / Q000037:antagonists & inhibitors / Q000502:physiology; D012772:Shock, Septic / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D013152:Splanchnic Circulation / Q000187:drug effects; D013552:Swine; D013777:Tetrazoles / Q000494:pharmacology*
chemical_list: D000098:Acetophenones; D008070:Lipopolysaccharides; D013189:SRS-A; D013777:Tetrazoles; C061324:LY 203647